Skip to main content
Access Resources

MJFF Publications

3921 - 3930 of 7407 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • RESTRICTED
    Title: Cross-Platform Comparison of Immunoassay Technologies to Assess Cytokine Markers in Patients With Post-Traumatic Stress Disorder and Parkinson’s Disease
    Journal Name: Biological Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.biopsych.2020.02.968
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Deciphering DDX3X Syndrome to Capture Determinants of Intellectual Disability
    Journal Name: Biological Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.biopsych.2020.02.969
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Do Parkinson disease subject and caregiver-reported Epworth sleepiness scale reponses correlate?
    Journal Name: Clinical Neurology and Neurosurgery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.clineuro.2020.105728
    Citation Count: 2
  • OPEN
    Title: ePresentation Sessions
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ene.14307
    Citation Count: 4
  • OPEN
    Title: Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients
    Journal Name: JAMA Oncology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaoncol.2020.0001
    Citation Count: 80
  • RESTRICTED
    Title: Expert comment: “A case of missing pathology in a patient with LRRK2 Parkinson's disease”
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.005
    Best OA location URL:
    Citation Count: 3
  • RESTRICTED
    Title: Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson’s Disease
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.02.046
    Best OA location URL:
    Citation Count: 18
  • RESTRICTED
    Title: Impact of Overweight and Obesity on Functional and Clinical Outcomes of Early Parkinson's Disease
    Journal Name: Journal of the American Medical Directors Association
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jamda.2019.11.019
    Best OA location URL:
    Citation Count: 9
  • RESTRICTED
    Title: Initiation of pharmacological therapy in Parkinson's disease: when, why, and how
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30036-3
    Best OA location URL:
    Citation Count: 96
  • OPEN
    Title: Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synuclein
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.aba1193
    Citation Count: 35
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.